Exact Mass: 1086.4051

Exact Mass Matches: 1086.4051

Found 19 metabolites which its exact mass value is equals to given mass value 1086.4051, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Triostin A

N-[(1R,4S,7R,11S,14R,17S,20R,24S)-2,4,12,15,17,25-hexamethyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28,29-dithia-2,5,12,15,18,25-hexazabicyclo[12.12.4]triacontan-7-yl]quinoxaline-2-carboxamide

C50H62N12O12S2 (1086.4051)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

Calyculin J

C50H80BrN4O15P (1086.4541)

epioritin-(4beta->3)-epioritin-(4beta->6)-epioritin-4beta-ol nona-O-methylether triacetate

C60H62O19 (1086.3885)

C52H76BrClO17

C52H76BrClO17 (1086.3954)

epioritin-(4beta->6)-epioritin-(4alpha->4)-epioritin-4beta-ol nona-O-methylether triacetate

C60H62O19 (1086.3885)

N-[(1R,4S,7R,11S,14R,17S,20R,24S)-2,4,12,15,17,25-hexamethyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28,29-dithia-2,5,12,15,18,25-hexazabicyclo[12.12.4]triacontan-7-yl]quinoxaline-2-carboxamide

C50H62N12O12S2 (1086.4051)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

GlcA(b1-3)Gal(b1-4)GlcNAc(b1-3)GalNAc(b1-3)Gal(b1-4)b-Glc

C40H66N2O32 (1086.3599)

NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]Gal(b1-4)b-Glc

C40H66N2O32 (1086.3599)

(2S,4S,5R,6R)-5-acetamido-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6S)-6-[(3R,4S,5S,6R)-4-[(2S,4S,5R,6R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

(2S,4S,5R,6R)-5-acetamido-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6S)-6-[(3R,4S,5S,6R)-4-[(2S,4S,5R,6R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C40H66N2O32 (1086.3599)

(2s,3s,4s)-n-[(3s)-3-{4-[(1e)-3-[(2r,3r,5r,7s,8s,9r)-2-[(1s,3s,4s)-4-[(2s,3s,4r,5s)-4-bromo-5-[(2e,4e,6z)-7-cyano-6-methylhepta-2,4,6-trien-2-yl]-3,5-dimethyloxolan-2-yl]-3-hydroxy-1-methoxypentyl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-7-yl]prop-1-en-1-yl]-1,3-oxazol-2-yl}butyl]-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanimidic acid

(2s,3s,4s)-n-[(3s)-3-{4-[(1e)-3-[(2r,3r,5r,7s,8s,9r)-2-[(1s,3s,4s)-4-[(2s,3s,4r,5s)-4-bromo-5-[(2e,4e,6z)-7-cyano-6-methylhepta-2,4,6-trien-2-yl]-3,5-dimethyloxolan-2-yl]-3-hydroxy-1-methoxypentyl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-7-yl]prop-1-en-1-yl]-1,3-oxazol-2-yl}butyl]-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanimidic acid

C50H80BrN4O15P (1086.4541)

n-(3-{4-[3-(2-{4-[4-bromo-5-(7-cyano-6-methylhepta-2,4,6-trien-2-yl)-3,5-dimethyloxolan-2-yl]-3-hydroxy-1-methoxypentyl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-7-yl)prop-1-en-1-yl]-1,3-oxazol-2-yl}butyl)-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanimidic acid

n-(3-{4-[3-(2-{4-[4-bromo-5-(7-cyano-6-methylhepta-2,4,6-trien-2-yl)-3,5-dimethyloxolan-2-yl]-3-hydroxy-1-methoxypentyl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-7-yl)prop-1-en-1-yl]-1,3-oxazol-2-yl}butyl)-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanimidic acid

C50H80BrN4O15P (1086.4541)

4-{[3-(acetyloxy)-6-[3-(acetyloxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]oxy}-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl acetate

4-{[3-(acetyloxy)-6-[3-(acetyloxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]oxy}-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl acetate

C60H62O19 (1086.3885)

(2r,3r,4s)-4-{[(2r,3r,4r)-3-(acetyloxy)-6-[(2r,3r,4r)-3-(acetyloxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]oxy}-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl acetate

(2r,3r,4s)-4-{[(2r,3r,4r)-3-(acetyloxy)-6-[(2r,3r,4r)-3-(acetyloxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]oxy}-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl acetate

C60H62O19 (1086.3885)

n-(6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28,29-dithia-2,5,12,15,18,25-hexaazabicyclo[12.12.4]triaconta-5,18-dien-7-yl)quinoxaline-2-carboximidic acid

n-(6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28,29-dithia-2,5,12,15,18,25-hexaazabicyclo[12.12.4]triaconta-5,18-dien-7-yl)quinoxaline-2-carboximidic acid

C50H62N12O12S2 (1086.4051)

(2r,3r,4r)-n-[(3r)-3-{4-[(1e)-3-[(2s,3s,5s,7r,8r,9s)-2-[(1r,3r,4r)-4-[(2r,3r,4s,5r)-4-bromo-5-[(2e,4e,6z)-7-cyano-6-methylhepta-2,4,6-trien-2-yl]-3,5-dimethyloxolan-2-yl]-3-hydroxy-1-methoxypentyl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-7-yl]prop-1-en-1-yl]-1,3-oxazol-2-yl}butyl]-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanimidic acid

(2r,3r,4r)-n-[(3r)-3-{4-[(1e)-3-[(2s,3s,5s,7r,8r,9s)-2-[(1r,3r,4r)-4-[(2r,3r,4s,5r)-4-bromo-5-[(2e,4e,6z)-7-cyano-6-methylhepta-2,4,6-trien-2-yl]-3,5-dimethyloxolan-2-yl]-3-hydroxy-1-methoxypentyl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-7-yl]prop-1-en-1-yl]-1,3-oxazol-2-yl}butyl]-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanimidic acid

C50H80BrN4O15P (1086.4541)

4-({4-[3,4-bis(acetyloxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-6-yl]-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl}oxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl acetate

4-({4-[3,4-bis(acetyloxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-6-yl]-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl}oxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl acetate

C60H62O19 (1086.3885)

(2r,3s,4s)-3-(acetyloxy)-6-[(2r,3r,4r)-3-{[(2r,3r,4s)-3-(acetyloxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]oxy}-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl acetate

(2r,3s,4s)-3-(acetyloxy)-6-[(2r,3r,4r)-3-{[(2r,3r,4s)-3-(acetyloxy)-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]oxy}-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-7,8-dimethoxy-2-(4-methoxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl acetate

C60H62O19 (1086.3885)

n-(3-{4-[(1e)-3-[2-(4-{4-bromo-5-[(2e,4e,6z)-7-cyano-6-methylhepta-2,4,6-trien-2-yl]-3,5-dimethyloxolan-2-yl}-3-hydroxy-1-methoxypentyl)-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-7-yl]prop-1-en-1-yl]-1,3-oxazol-2-yl}butyl)-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanimidic acid

n-(3-{4-[(1e)-3-[2-(4-{4-bromo-5-[(2e,4e,6z)-7-cyano-6-methylhepta-2,4,6-trien-2-yl]-3,5-dimethyloxolan-2-yl}-3-hydroxy-1-methoxypentyl)-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-7-yl]prop-1-en-1-yl]-1,3-oxazol-2-yl}butyl)-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanimidic acid

C50H80BrN4O15P (1086.4541)

n-[(1s,4s,7r,11s,14s,17s,20r,24s)-6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28,29-dithia-2,5,12,15,18,25-hexaazabicyclo[12.12.4]triaconta-5,18-dien-7-yl]quinoxaline-2-carboximidic acid

n-[(1s,4s,7r,11s,14s,17s,20r,24s)-6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28,29-dithia-2,5,12,15,18,25-hexaazabicyclo[12.12.4]triaconta-5,18-dien-7-yl]quinoxaline-2-carboximidic acid

C50H62N12O12S2 (1086.4051)